Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 7. New horizons in beta-adrenoceptor blockade therapy: Labetalol
- 30 November 1979
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 98 (5) , 660-665
- https://doi.org/10.1016/0002-8703(79)90294-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effects of phentolamine inhalation on patients with bronchial asthma.Published by Wiley ,1975
- Comparison of intravenous AH 5158 (ibidomide) and propranolol in asthma.BMJ, 1975
- ALPHA-RECEPTOR-BLOCKING DRUGS IN BRONCHIAL ASTHMAThe Lancet, 1975
- Pharmacology of AH 5158; a drug which blocks both α‐ and β‐adrenoceptorsBritish Journal of Pharmacology, 1972
- Clinical investigation of an antagonist at α‐ and β‐adrenoceptors‐AH 5158ABritish Journal of Pharmacology, 1972
- Preliminary Studies of the Pharmacological Effects of 5-{1-Hydroxy-2-[(1-Methyl-3-Phenylpropyl) Amino]-Ethyl}Salicylamide (AH 5158) in ManClinical Science, 1971
- Plasma Propranolol Levels in the Quantitative Assessment of -adrenergic Blockade in ManBMJ, 1970
- Evidence for existence of alpha-adrenergic receptors in the mammalian tracheaAmerican Journal of Physiology-Legacy Content, 1970
- Effects of -Adrenergic Receptor Blockade on Airway Conductance and Lung Volume in Normal and Asthmatic SubjectsBMJ, 1969
- A STUDY OF THE ADRENOTROPIC RECEPTORSAmerican Journal of Physiology-Legacy Content, 1948